HealthEngland RSV and COVID-19 Hospital Admission Rates Both RiseBy Naomi CalderOct 15, 2026, 5:14 PM UTC
BusinessTESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in GermanyBy Nasdaq OMXDec 15, 2017, 9:00 AM UTC
